Prevention of oesophagitis, gastric and duodenal lesions in patients taking antithrombotic low-dose aspirin with famotidine
Phase 1
- Conditions
- Peptic ulceration induced by low-dose aspirin
- Registration Number
- EUCTR2005-004849-33-GB
- Lead Sponsor
- HS Greater Glasgow
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 700
Inclusion Criteria
Adult patients, aged 18 years or over, using low-dose aspirin (75-325 mg daily) for vascular protection
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Unstable or uncontrolled cardiovascular or systemic diseases. Significant endoscopic abnormalities at base-line endoscopy
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method